Both in Pharmaceuticals
Genprex vs PMGC Holdings
Over the past year GNPX returned −98.0% and ELAB returned −99.9%; their daily moves had a correlation of -0.00.
GNPX −98.0% ELAB −99.9%Growth of $1, one year, split-adjusted
| Metric | GNPX | ELAB |
|---|---|---|
| Price | $2.31 | $1.94 |
| Market cap | $1.9M | $1.6M |
| Today | +3.59% | −7.62% |
| 1 month | −15.1% | −40.7% |
| 6 months | −88.1% | −91.2% |
| Year to date | −94.0% | −99.5% |
| 1 year | −98.2% | −99.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 29.5% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.6× |
| Net cash | $15.2M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 81.9% | 677.7% |
| Short % of float | 15.3% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).